JP2002282219A - Intracorporeal capsule - Google Patents
Intracorporeal capsuleInfo
- Publication number
- JP2002282219A JP2002282219A JP2001082108A JP2001082108A JP2002282219A JP 2002282219 A JP2002282219 A JP 2002282219A JP 2001082108 A JP2001082108 A JP 2001082108A JP 2001082108 A JP2001082108 A JP 2001082108A JP 2002282219 A JP2002282219 A JP 2002282219A
- Authority
- JP
- Japan
- Prior art keywords
- capsule
- battery
- processing circuit
- power supply
- processing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y02E60/12—
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、動物の体内や人体
の皮下組織等に埋め込まれる体内カプセルに関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an in-vivo capsule to be implanted in an animal body or a subcutaneous tissue of a human body.
【0002】[0002]
【従来の技術】従来から動物の体内に発信機を埋め込む
ことにより、その個体の所在地や生息場所、活動範囲等
を観察する試みがなされている。また、人体において
も、心臓ペースメーカ等の機器が埋め込まれる場合があ
る。動物の体内や人体に埋め込まれる各種の機器は動作
電源が必要であり、通常は動作電源として電池が用いら
れる。2. Description of the Related Art Conventionally, attempts have been made to observe the location, habitat, activity range, and the like of an individual by implanting a transmitter in the body of an animal. Also, a device such as a cardiac pacemaker may be implanted in the human body. Various devices embedded in the body of an animal or a human body require an operation power supply, and a battery is usually used as the operation power supply.
【0003】[0003]
【発明が解決しようとする課題】ところで、上述した動
物の体内等に埋め込まれる各種の機器は、電池で動作し
ており、電池の寿命とともに動作が停止するため、この
寿命以上の長期間にわたってこれらの機器を使用したい
場合には、体内に埋め込まれた機器を一旦体外に取り出
して、電池交換の後、あるいは電池を含む機器自体を新
規なものに取り替えた後に、再度体内に埋め込む必要が
あった。この作業は外科手術的な処置を要するため、こ
の機器を埋め込まれる動物等の負担が大きく、しかも電
池の寿命に達する前に行う必要があるためその期限管理
が必要になるという煩雑さを伴う。The above-described various devices implanted in the body of an animal or the like operate on batteries, and stop operating with the life of the batteries. If you want to use this device, you need to take out the device implanted inside the body once, replace the battery, or replace the device including the battery itself with a new one, and then reinsert it inside the body . Since this operation requires a surgical operation, the burden on an animal or the like in which the device is implanted is large, and the operation must be performed before the life of the battery has been reached.
【0004】本発明は、このような点に鑑みて創作され
たものであり、その目的は、電池交換が不要であって、
長期間にわたって継続的な動作が可能な体内カプセルを
提供することにある。[0004] The present invention has been made in view of the above points, and its purpose is to eliminate the need for battery replacement.
An object of the present invention is to provide a capsule capable of continuous operation for a long period of time.
【0005】[0005]
【課題を解決するための手段】上述した課題を解決する
ために、本発明の体内カプセルは、生物の体内に埋め込
まれるものであって、体内組織に含まれる体液を電解液
として用いることにより電流を取り出す電源部を備えて
いる。体内組織に含まれる体液を電解液として用いる電
池が備わっているため、電池交換が不要であり、長期間
にわたって体内カプセルの継続的な動作が可能になる。Means for Solving the Problems In order to solve the above-mentioned problems, the in-vivo capsule of the present invention is to be implanted in the body of an organism, and uses a body fluid contained in the body tissue as an electrolytic solution. A power supply unit for taking out Since a battery using a body fluid contained in a body tissue as an electrolyte is provided, battery replacement is not required, and continuous operation of the body capsule can be performed for a long period of time.
【0006】また、上述した電源部から供給される電流
を用いて所定の処理を行う処理回路と、上述した電源部
から供給される電流を用いて処理回路の処理結果を外部
に送信する送信部とを備えることが望ましい。処理回路
と送信部を備えることにより、体内カプセル内で処理し
た結果を体外に送信することが可能になる。Further, a processing circuit for performing a predetermined process using the current supplied from the power supply unit, and a transmission unit for transmitting the processing result of the processing circuit to the outside using the current supplied from the power supply unit It is desirable to provide The provision of the processing circuit and the transmission unit makes it possible to transmit the result of processing in the in-vivo capsule to the outside of the body.
【0007】特に、体内の状態を検出するセンサをさら
に備えるとともに、上述した処理回路は、このセンサか
ら出力される検出信号を処理して送信データを作成する
処理を行い、この送信データを送信部によって送信する
ことが望ましい。例えば、体温センサや心拍数センサ等
を考えると、こられの検出結果を電池交換せずに長期間
にわたって体内カプセルから体外に送信することが可能
になるため、体内の状態を継続的に、しかも特別な接続
線等を用いることなく監視することができる。In particular, the apparatus further includes a sensor for detecting a state inside the body, and the above-described processing circuit performs processing for processing a detection signal output from the sensor to generate transmission data, and transmits the transmission data to a transmission unit. It is desirable to send by. For example, considering a body temperature sensor, a heart rate sensor, and the like, it is possible to transmit these detection results from the body capsule to the outside of the body for a long period of time without replacing the battery. Monitoring can be performed without using a special connection line or the like.
【0008】[0008]
【発明の実施の形態】以下、本発明を適用した一実施形
態の体内カプセルについて詳細に説明する。図1は、本
発明を適用した一実施形態の体内カプセルの設置状態を
示す図である。図1に示すように、本実施形態の体内カ
プセル110は、皮膚100の直下の皮下組織102内
に埋め込まれる。なお、一例として、体内カプセル11
0を皮下組織102に埋め込むようにしたが、それ以外
に体内の臓器間の間室に埋め込む場合やその他の部位に
埋め込むようにしてもよい。BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, an in-vivo capsule according to an embodiment of the present invention will be described in detail. FIG. 1 is a diagram showing an installed state of an in-vivo capsule according to an embodiment to which the present invention is applied. As shown in FIG. 1, the in-vivo capsule 110 of the present embodiment is embedded in the subcutaneous tissue 102 immediately below the skin 100. In addition, as an example, the body capsule 11
Although “0” is embedded in the subcutaneous tissue 102, it may be embedded in an interstitial space between organs in the body or in other parts.
【0009】図2は、体内カプセル110の詳細な構成
を示す図である。図2に示すように、体内カプセル11
0は、皮下組織102から供給される体液を電解液とし
て使用する電池10と、この電池10によって供給され
る電流によって動作する各種の回路(後述する)が搭載
された処理基板20と、体内カプセル110周辺の体温
を検出する体温センサ30と、体内カプセル110周辺
の圧力変動に基づく心拍数の検出を行う心拍数センサ3
2と、体内カプセル110の内壁に沿って配置されたア
ンテナ34とを備えている。FIG. 2 is a diagram showing a detailed configuration of the in-vivo capsule 110. As shown in FIG.
Reference numeral 0 denotes a battery 10 that uses a body fluid supplied from the subcutaneous tissue 102 as an electrolytic solution, a processing substrate 20 on which various circuits (described later) operated by an electric current supplied by the battery 10 are mounted, and a body capsule. A body temperature sensor 30 for detecting a body temperature around 110 and a heart rate sensor 3 for detecting a heart rate based on pressure fluctuation around the body capsule 110
2 and an antenna 34 arranged along the inner wall of the body capsule 110.
【0010】電池10は、2種類の電極11、12を複
数組備えており、各組の電極11、12の間が、皮下組
織102から供給される体液によって充填されるように
なっている。皮下組織102内に存在する体液(リンパ
液)は電解液であるため、この電解液に浸した2種類の
電極には電位差が現れる。本実施形態では、このような
電極構造が複数組並べられており、これらを直列接続す
ることにより、電池10の出力電圧が所定値以上(例え
ば、後述する処理回路24や送信回路26の動作電圧を
生成するために充分な電圧値以上)になるように設定さ
れている。The battery 10 has a plurality of sets of two types of electrodes 11 and 12, and the space between each set of electrodes 11 and 12 is filled with a body fluid supplied from a subcutaneous tissue 102. Since the body fluid (lymph fluid) existing in the subcutaneous tissue 102 is an electrolytic solution, a potential difference appears between the two types of electrodes immersed in the electrolytic solution. In the present embodiment, a plurality of such electrode structures are arranged, and by connecting them in series, the output voltage of the battery 10 is equal to or higher than a predetermined value (for example, the operating voltage of the processing circuit 24 and the transmission circuit 26 described later). Is set to a voltage value sufficient to generate the
【0011】図3は、処理基板20に搭載される回路の
具体例を示す図である。図3に示すように、処理基板2
0には、電源回路22、処理回路24、送信回路26が
搭載されている。電源回路22は、上述した電池10と
ともに電源部を構成しており、所定の動作電圧(例えば
1.5V程度の電圧)を生成する。この電源回路22か
ら供給される電流によって、処理回路24および送信回
路26が動作する。処理回路24は、体温センサ30お
よび心拍数センサ32が接続されており、これらの各セ
ンサから出力される検出信号を処理して、体温および心
拍数を示す送信データを作成する。送信回路26は、上
述したアンテナ34とともに送信部を構成しており、処
理回路24が作成した送信データをアンテナ34を介し
て体内カプセル110の外部に送信する。この送信デー
タは、例えば皮膚100の表面に配置された受信部(図
示せず)によって受信されて収集され、体内の状態の観
察や診断を行うために用いられる。FIG. 3 is a diagram showing a specific example of a circuit mounted on the processing substrate 20. As shown in FIG. As shown in FIG.
In 0, a power supply circuit 22, a processing circuit 24, and a transmission circuit 26 are mounted. The power supply circuit 22 constitutes a power supply unit together with the battery 10 described above, and generates a predetermined operation voltage (for example, a voltage of about 1.5 V). The processing circuit 24 and the transmission circuit 26 operate by the current supplied from the power supply circuit 22. The processing circuit 24 is connected to the body temperature sensor 30 and the heart rate sensor 32, and processes detection signals output from these sensors to generate transmission data indicating the body temperature and the heart rate. The transmission circuit 26 constitutes a transmission unit together with the above-mentioned antenna 34, and transmits the transmission data created by the processing circuit 24 to the outside of the in-vivo capsule 110 via the antenna 34. The transmission data is received and collected by, for example, a receiving unit (not shown) arranged on the surface of the skin 100, and is used for observing and diagnosing a state in the body.
【0012】このように、本実施形態の体内カプセル1
10は、皮下組織102に埋め込まれた状態で電池10
内に体液が充填され、所定の動作電圧が生成される。し
たがって、体液が電池10内に供給されてこの動作電圧
の生成が継続的に行われるため、従来のように電池交換
が不要であって、長期間にわたって体内カプセル110
の継続的な動作が可能になる。As described above, the in-vivo capsule 1 of the present embodiment is
The battery 10 is embedded in the subcutaneous tissue 102.
Is filled with a bodily fluid, and a predetermined operating voltage is generated. Therefore, since the body fluid is supplied into the battery 10 and the operation voltage is continuously generated, the battery replacement is not necessary as in the conventional case, and the body capsule 110 is not used for a long time.
Can be operated continuously.
【0013】特に、体内カプセル110には、体温セン
サ30や心拍数センサ32が備わっており、これらの各
センサの検出信号に基づいて体温や心拍数を示す送信デ
ータが作成され、体内カプセル110および体外に送信
されるため、この送信データを受信して所定の処理を行
うことにより、体内の状態を継続的に、しかも特別な接
続線等を用いることなく監視、診断することが可能にな
る。In particular, the body capsule 110 is provided with a body temperature sensor 30 and a heart rate sensor 32. Transmission data indicating the body temperature and the heart rate are created based on the detection signals of these sensors, and the body capsule 110 and the heart rate sensor 32 are generated. Since the data is transmitted outside the body, by receiving the transmission data and performing a predetermined process, it is possible to continuously monitor and diagnose the state of the body without using a special connection line or the like.
【0014】なお、本発明は上記実施形態に限定される
ものではなく、本発明の要旨の範囲内において種々の変
形実施が可能である。例えば、上述した実施形態では、
体温センサ30と心拍数センサ32を備える場合を例に
とって説明したが、それ以外のセンサを備えるようにし
てもよい。The present invention is not limited to the above-described embodiment, and various modifications can be made within the scope of the present invention. For example, in the embodiment described above,
Although the case where the body temperature sensor 30 and the heart rate sensor 32 are provided has been described as an example, other sensors may be provided.
【0015】また、上述した実施形態では、電源回路2
2によって生成した動作電圧を処理回路24および送信
回路26に直接印加するようにしたが、図4に示すよう
に、充電回路28を用いて二次電池29を充電し、この
充電電圧を用いて電源回路22によって動作電圧を生成
するようにしてもよい。この場合には、電池10の発生
電圧が変動する場合であっても、常に一定の動作電圧を
生成することが可能になる。In the above-described embodiment, the power supply circuit 2
The operation voltage generated by the operation circuit 2 is directly applied to the processing circuit 24 and the transmission circuit 26. However, as shown in FIG. 4, the secondary battery 29 is charged by using the charging circuit 28, and the charging voltage is used by using this charging voltage. The operating voltage may be generated by the power supply circuit 22. In this case, even if the generated voltage of the battery 10 fluctuates, it is possible to always generate a constant operating voltage.
【0016】[0016]
【発明の効果】上述したように、本発明によれば、体内
組織に含まれる体液を電解液として用いる電池が備わっ
ているため、電池交換が不要であり、長期間にわたって
体内カプセルの継続的な動作が可能になる。As described above, according to the present invention, since a battery using a body fluid contained in a body tissue as an electrolyte is provided, there is no need to replace the battery, and the body capsule can be continuously used for a long period of time. Operation becomes possible.
【図1】一実施形態の体内カプセルの設置状態を示す図
である。FIG. 1 is a view showing an installed state of an in-vivo capsule according to an embodiment.
【図2】体内カプセルの詳細な構成を示す図である。FIG. 2 is a diagram showing a detailed configuration of a body capsule.
【図3】処理基板に搭載される回路の具体例を示す図で
ある。FIG. 3 is a diagram showing a specific example of a circuit mounted on a processing substrate.
【図4】処理基板に搭載される回路の変形例を示す図で
ある。FIG. 4 is a diagram showing a modified example of a circuit mounted on a processing substrate.
10 電池 20 処理基板 22 電源回路 24 処理回路 26 送信回路 28 充電回路 29 二次電池 30 体温センサ 32 心拍数センサ 34 アンテナ 110 体内カプセル DESCRIPTION OF SYMBOLS 10 Battery 20 Processing board 22 Power supply circuit 24 Processing circuit 26 Transmission circuit 28 Charging circuit 29 Secondary battery 30 Body temperature sensor 32 Heart rate sensor 34 Antenna 110 In-vivo capsule
───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4C017 AA02 AA10 AA16 AB10 AC16 EE01 FF05 FF15 FF17 5H025 AA13 BB12 BB18 CC16 ──────────────────────────────────────────────────続 き Continued on the front page F term (reference) 4C017 AA02 AA10 AA16 AB10 AC16 EE01 FF05 FF15 FF17 5H025 AA13 BB12 BB18 CC16
Claims (3)
であって、 体内組織に含まれる体液を電解液として用いることによ
り電流を取り出す電源部を備えることを特徴とする体内
カプセル。1. An in-vivo capsule embedded in a living body, comprising a power supply unit for extracting an electric current by using a body fluid contained in a body tissue as an electrolyte.
う処理回路と、 前記電源部から供給される電流を用いて、前記処理回路
の処理結果を外部に送信する送信部と、 を備えることを特徴とする体内カプセル。2. The processing circuit according to claim 1, wherein the processing circuit performs predetermined processing using a current supplied from the power supply unit, and outputs a processing result of the processing circuit to an external device using the current supplied from the power supply unit. And a transmitting unit for transmitting to the body capsule.
処理して送信データを作成する処理を行い、 前記送信部は、前記送信データの送信を行うことを特徴
とする体内カプセル。3. The transmission unit according to claim 2, further comprising a sensor for detecting a state inside the body, wherein the processing circuit performs a process of generating a transmission data by processing a detection signal output from the sensor. A body capsule for transmitting said transmission data.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001082108A JP2002282219A (en) | 2001-03-22 | 2001-03-22 | Intracorporeal capsule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001082108A JP2002282219A (en) | 2001-03-22 | 2001-03-22 | Intracorporeal capsule |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002282219A true JP2002282219A (en) | 2002-10-02 |
Family
ID=18938098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001082108A Pending JP2002282219A (en) | 2001-03-22 | 2001-03-22 | Intracorporeal capsule |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2002282219A (en) |
Cited By (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010522409A (en) * | 2007-02-14 | 2010-07-01 | プロテウス バイオメディカル インコーポレイテッド | Internal power supply with large surface area electrode |
CN103259027A (en) * | 2005-04-28 | 2013-08-21 | 普罗透斯数字保健公司 | Pharma-informatics system |
JP2014221197A (en) * | 2003-09-11 | 2014-11-27 | セラノス, インコーポレイテッド | Medical device for monitoring of specimen and delivery of medicine |
US9149577B2 (en) | 2008-12-15 | 2015-10-06 | Proteus Digital Health, Inc. | Body-associated receiver and method |
US9149423B2 (en) | 2009-05-12 | 2015-10-06 | Proteus Digital Health, Inc. | Ingestible event markers comprising an ingestible component |
US9161707B2 (en) | 2005-04-28 | 2015-10-20 | Proteus Digital Health, Inc. | Communication system incorporated in an ingestible product |
US9198608B2 (en) | 2005-04-28 | 2015-12-01 | Proteus Digital Health, Inc. | Communication system incorporated in a container |
US9258035B2 (en) | 2008-03-05 | 2016-02-09 | Proteus Digital Health, Inc. | Multi-mode communication ingestible event markers and systems, and methods of using the same |
US9270025B2 (en) | 2007-03-09 | 2016-02-23 | Proteus Digital Health, Inc. | In-body device having deployable antenna |
US9268909B2 (en) | 2012-10-18 | 2016-02-23 | Proteus Digital Health, Inc. | Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device |
US9270503B2 (en) | 2013-09-20 | 2016-02-23 | Proteus Digital Health, Inc. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
US9271897B2 (en) | 2012-07-23 | 2016-03-01 | Proteus Digital Health, Inc. | Techniques for manufacturing ingestible event markers comprising an ingestible component |
US9320455B2 (en) | 2009-04-28 | 2016-04-26 | Proteus Digital Health, Inc. | Highly reliable ingestible event markers and methods for using the same |
US9415010B2 (en) | 2008-08-13 | 2016-08-16 | Proteus Digital Health, Inc. | Ingestible circuitry |
US9433371B2 (en) | 2007-09-25 | 2016-09-06 | Proteus Digital Health, Inc. | In-body device with virtual dipole signal amplification |
US9444503B2 (en) | 2006-11-20 | 2016-09-13 | Proteus Digital Health, Inc. | Active signal processing personal health signal receivers |
US9439582B2 (en) | 2005-04-28 | 2016-09-13 | Proteus Digital Health, Inc. | Communication system with remote activation |
US9439599B2 (en) | 2011-03-11 | 2016-09-13 | Proteus Digital Health, Inc. | Wearable personal body associated device with various physical configurations |
US9439566B2 (en) | 2008-12-15 | 2016-09-13 | Proteus Digital Health, Inc. | Re-wearable wireless device |
US9577864B2 (en) | 2013-09-24 | 2017-02-21 | Proteus Digital Health, Inc. | Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance |
US9597010B2 (en) | 2005-04-28 | 2017-03-21 | Proteus Digital Health, Inc. | Communication system using an implantable device |
US9597487B2 (en) | 2010-04-07 | 2017-03-21 | Proteus Digital Health, Inc. | Miniature ingestible device |
US9603550B2 (en) | 2008-07-08 | 2017-03-28 | Proteus Digital Health, Inc. | State characterization based on multi-variate data fusion techniques |
US9659423B2 (en) | 2008-12-15 | 2017-05-23 | Proteus Digital Health, Inc. | Personal authentication apparatus system and method |
US9756874B2 (en) | 2011-07-11 | 2017-09-12 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
US9796576B2 (en) | 2013-08-30 | 2017-10-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
CN107307853A (en) * | 2017-06-02 | 2017-11-03 | 唐山金万众科技有限公司 | A kind of capsule monitoring device |
JP2017208332A (en) * | 2011-07-11 | 2017-11-24 | プロテウス デジタル ヘルス, インコーポレイテッド | Method for manufacturing communication device and communication device |
CN107404997A (en) * | 2014-12-05 | 2017-11-28 | Nmr技术股份有限公司 | For discharging the electrochemical appliance of ion |
US9883819B2 (en) | 2009-01-06 | 2018-02-06 | Proteus Digital Health, Inc. | Ingestion-related biofeedback and personalized medical therapy method and system |
US9941931B2 (en) | 2009-11-04 | 2018-04-10 | Proteus Digital Health, Inc. | System for supply chain management |
US10084880B2 (en) | 2013-11-04 | 2018-09-25 | Proteus Digital Health, Inc. | Social media networking based on physiologic information |
US10175376B2 (en) | 2013-03-15 | 2019-01-08 | Proteus Digital Health, Inc. | Metal detector apparatus, system, and method |
US10187121B2 (en) | 2016-07-22 | 2019-01-22 | Proteus Digital Health, Inc. | Electromagnetic sensing and detection of ingestible event markers |
US10223905B2 (en) | 2011-07-21 | 2019-03-05 | Proteus Digital Health, Inc. | Mobile device and system for detection and communication of information received from an ingestible device |
US10238604B2 (en) | 2006-10-25 | 2019-03-26 | Proteus Digital Health, Inc. | Controlled activation ingestible identifier |
US10376218B2 (en) | 2010-02-01 | 2019-08-13 | Proteus Digital Health, Inc. | Data gathering system |
US10398161B2 (en) | 2014-01-21 | 2019-09-03 | Proteus Digital Heal Th, Inc. | Masticable ingestible product and communication system therefor |
US10441194B2 (en) | 2007-02-01 | 2019-10-15 | Proteus Digital Heal Th, Inc. | Ingestible event marker systems |
US10517506B2 (en) | 2007-05-24 | 2019-12-31 | Proteus Digital Health, Inc. | Low profile antenna for in body device |
US10529044B2 (en) | 2010-05-19 | 2020-01-07 | Proteus Digital Health, Inc. | Tracking and delivery confirmation of pharmaceutical products |
US11051543B2 (en) | 2015-07-21 | 2021-07-06 | Otsuka Pharmaceutical Co. Ltd. | Alginate on adhesive bilayer laminate film |
US11149123B2 (en) | 2013-01-29 | 2021-10-19 | Otsuka Pharmaceutical Co., Ltd. | Highly-swellable polymeric films and compositions comprising the same |
US11158149B2 (en) | 2013-03-15 | 2021-10-26 | Otsuka Pharmaceutical Co., Ltd. | Personal authentication apparatus system and method |
US11504511B2 (en) | 2010-11-22 | 2022-11-22 | Otsuka Pharmaceutical Co., Ltd. | Ingestible device with pharmaceutical product |
US11529071B2 (en) | 2016-10-26 | 2022-12-20 | Otsuka Pharmaceutical Co., Ltd. | Methods for manufacturing capsules with ingestible event markers |
US11744481B2 (en) | 2013-03-15 | 2023-09-05 | Otsuka Pharmaceutical Co., Ltd. | System, apparatus and methods for data collection and assessing outcomes |
US11928614B2 (en) | 2006-05-02 | 2024-03-12 | Otsuka Pharmaceutical Co., Ltd. | Patient customized therapeutic regimens |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63118686A (en) * | 1986-11-06 | 1988-05-23 | Seiko Epson Corp | Biotimepiece |
JPH0542173A (en) * | 1991-08-05 | 1993-02-23 | Dentistry Reserchers & Designers Inc | Method for confirming identity of human or animal |
JP2000005136A (en) * | 1998-06-26 | 2000-01-11 | Nippon Telegr & Teleph Corp <Ntt> | Temperature measuring device and implant |
-
2001
- 2001-03-22 JP JP2001082108A patent/JP2002282219A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63118686A (en) * | 1986-11-06 | 1988-05-23 | Seiko Epson Corp | Biotimepiece |
JPH0542173A (en) * | 1991-08-05 | 1993-02-23 | Dentistry Reserchers & Designers Inc | Method for confirming identity of human or animal |
JP2000005136A (en) * | 1998-06-26 | 2000-01-11 | Nippon Telegr & Teleph Corp <Ntt> | Temperature measuring device and implant |
Cited By (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014221197A (en) * | 2003-09-11 | 2014-11-27 | セラノス, インコーポレイテッド | Medical device for monitoring of specimen and delivery of medicine |
US10130283B2 (en) | 2003-09-11 | 2018-11-20 | Theranos, IP Company, LLC | Medical device for analyte monitoring and drug delivery |
US10610128B2 (en) | 2005-04-28 | 2020-04-07 | Proteus Digital Health, Inc. | Pharma-informatics system |
US9962107B2 (en) | 2005-04-28 | 2018-05-08 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
US10542909B2 (en) | 2005-04-28 | 2020-01-28 | Proteus Digital Health, Inc. | Communication system with partial power source |
US9161707B2 (en) | 2005-04-28 | 2015-10-20 | Proteus Digital Health, Inc. | Communication system incorporated in an ingestible product |
US9198608B2 (en) | 2005-04-28 | 2015-12-01 | Proteus Digital Health, Inc. | Communication system incorporated in a container |
US9649066B2 (en) | 2005-04-28 | 2017-05-16 | Proteus Digital Health, Inc. | Communication system with partial power source |
US9597010B2 (en) | 2005-04-28 | 2017-03-21 | Proteus Digital Health, Inc. | Communication system using an implantable device |
US9439582B2 (en) | 2005-04-28 | 2016-09-13 | Proteus Digital Health, Inc. | Communication system with remote activation |
US10517507B2 (en) | 2005-04-28 | 2019-12-31 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
CN103259027A (en) * | 2005-04-28 | 2013-08-21 | 普罗透斯数字保健公司 | Pharma-informatics system |
US9681842B2 (en) | 2005-04-28 | 2017-06-20 | Proteus Digital Health, Inc. | Pharma-informatics system |
US11476952B2 (en) | 2005-04-28 | 2022-10-18 | Otsuka Pharmaceutical Co., Ltd. | Pharma-informatics system |
US11928614B2 (en) | 2006-05-02 | 2024-03-12 | Otsuka Pharmaceutical Co., Ltd. | Patient customized therapeutic regimens |
US11357730B2 (en) | 2006-10-25 | 2022-06-14 | Otsuka Pharmaceutical Co., Ltd. | Controlled activation ingestible identifier |
US10238604B2 (en) | 2006-10-25 | 2019-03-26 | Proteus Digital Health, Inc. | Controlled activation ingestible identifier |
US9444503B2 (en) | 2006-11-20 | 2016-09-13 | Proteus Digital Health, Inc. | Active signal processing personal health signal receivers |
US10441194B2 (en) | 2007-02-01 | 2019-10-15 | Proteus Digital Heal Th, Inc. | Ingestible event marker systems |
JP2010522409A (en) * | 2007-02-14 | 2010-07-01 | プロテウス バイオメディカル インコーポレイテッド | Internal power supply with large surface area electrode |
US11464423B2 (en) | 2007-02-14 | 2022-10-11 | Otsuka Pharmaceutical Co., Ltd. | In-body power source having high surface area electrode |
US9270025B2 (en) | 2007-03-09 | 2016-02-23 | Proteus Digital Health, Inc. | In-body device having deployable antenna |
US10517506B2 (en) | 2007-05-24 | 2019-12-31 | Proteus Digital Health, Inc. | Low profile antenna for in body device |
US9433371B2 (en) | 2007-09-25 | 2016-09-06 | Proteus Digital Health, Inc. | In-body device with virtual dipole signal amplification |
US9258035B2 (en) | 2008-03-05 | 2016-02-09 | Proteus Digital Health, Inc. | Multi-mode communication ingestible event markers and systems, and methods of using the same |
US11217342B2 (en) | 2008-07-08 | 2022-01-04 | Otsuka Pharmaceutical Co., Ltd. | Ingestible event marker data framework |
US9603550B2 (en) | 2008-07-08 | 2017-03-28 | Proteus Digital Health, Inc. | State characterization based on multi-variate data fusion techniques |
US10682071B2 (en) | 2008-07-08 | 2020-06-16 | Proteus Digital Health, Inc. | State characterization based on multi-variate data fusion techniques |
US9415010B2 (en) | 2008-08-13 | 2016-08-16 | Proteus Digital Health, Inc. | Ingestible circuitry |
US9659423B2 (en) | 2008-12-15 | 2017-05-23 | Proteus Digital Health, Inc. | Personal authentication apparatus system and method |
US9439566B2 (en) | 2008-12-15 | 2016-09-13 | Proteus Digital Health, Inc. | Re-wearable wireless device |
US9149577B2 (en) | 2008-12-15 | 2015-10-06 | Proteus Digital Health, Inc. | Body-associated receiver and method |
US9883819B2 (en) | 2009-01-06 | 2018-02-06 | Proteus Digital Health, Inc. | Ingestion-related biofeedback and personalized medical therapy method and system |
US10588544B2 (en) | 2009-04-28 | 2020-03-17 | Proteus Digital Health, Inc. | Highly reliable ingestible event markers and methods for using the same |
US9320455B2 (en) | 2009-04-28 | 2016-04-26 | Proteus Digital Health, Inc. | Highly reliable ingestible event markers and methods for using the same |
US9149423B2 (en) | 2009-05-12 | 2015-10-06 | Proteus Digital Health, Inc. | Ingestible event markers comprising an ingestible component |
US10305544B2 (en) | 2009-11-04 | 2019-05-28 | Proteus Digital Health, Inc. | System for supply chain management |
US9941931B2 (en) | 2009-11-04 | 2018-04-10 | Proteus Digital Health, Inc. | System for supply chain management |
US10376218B2 (en) | 2010-02-01 | 2019-08-13 | Proteus Digital Health, Inc. | Data gathering system |
US11173290B2 (en) | 2010-04-07 | 2021-11-16 | Otsuka Pharmaceutical Co., Ltd. | Miniature ingestible device |
US10207093B2 (en) | 2010-04-07 | 2019-02-19 | Proteus Digital Health, Inc. | Miniature ingestible device |
US9597487B2 (en) | 2010-04-07 | 2017-03-21 | Proteus Digital Health, Inc. | Miniature ingestible device |
US10529044B2 (en) | 2010-05-19 | 2020-01-07 | Proteus Digital Health, Inc. | Tracking and delivery confirmation of pharmaceutical products |
US11504511B2 (en) | 2010-11-22 | 2022-11-22 | Otsuka Pharmaceutical Co., Ltd. | Ingestible device with pharmaceutical product |
US9439599B2 (en) | 2011-03-11 | 2016-09-13 | Proteus Digital Health, Inc. | Wearable personal body associated device with various physical configurations |
US11229378B2 (en) | 2011-07-11 | 2022-01-25 | Otsuka Pharmaceutical Co., Ltd. | Communication system with enhanced partial power source and method of manufacturing same |
JP2017208332A (en) * | 2011-07-11 | 2017-11-24 | プロテウス デジタル ヘルス, インコーポレイテッド | Method for manufacturing communication device and communication device |
US9756874B2 (en) | 2011-07-11 | 2017-09-12 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
US10223905B2 (en) | 2011-07-21 | 2019-03-05 | Proteus Digital Health, Inc. | Mobile device and system for detection and communication of information received from an ingestible device |
US9271897B2 (en) | 2012-07-23 | 2016-03-01 | Proteus Digital Health, Inc. | Techniques for manufacturing ingestible event markers comprising an ingestible component |
US9268909B2 (en) | 2012-10-18 | 2016-02-23 | Proteus Digital Health, Inc. | Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device |
US11149123B2 (en) | 2013-01-29 | 2021-10-19 | Otsuka Pharmaceutical Co., Ltd. | Highly-swellable polymeric films and compositions comprising the same |
US10175376B2 (en) | 2013-03-15 | 2019-01-08 | Proteus Digital Health, Inc. | Metal detector apparatus, system, and method |
US11741771B2 (en) | 2013-03-15 | 2023-08-29 | Otsuka Pharmaceutical Co., Ltd. | Personal authentication apparatus system and method |
US11744481B2 (en) | 2013-03-15 | 2023-09-05 | Otsuka Pharmaceutical Co., Ltd. | System, apparatus and methods for data collection and assessing outcomes |
US11158149B2 (en) | 2013-03-15 | 2021-10-26 | Otsuka Pharmaceutical Co., Ltd. | Personal authentication apparatus system and method |
US10421658B2 (en) | 2013-08-30 | 2019-09-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
US9796576B2 (en) | 2013-08-30 | 2017-10-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
US9787511B2 (en) | 2013-09-20 | 2017-10-10 | Proteus Digital Health, Inc. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
US9270503B2 (en) | 2013-09-20 | 2016-02-23 | Proteus Digital Health, Inc. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
US11102038B2 (en) | 2013-09-20 | 2021-08-24 | Otsuka Pharmaceutical Co., Ltd. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
US10097388B2 (en) | 2013-09-20 | 2018-10-09 | Proteus Digital Health, Inc. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
US10498572B2 (en) | 2013-09-20 | 2019-12-03 | Proteus Digital Health, Inc. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
US9577864B2 (en) | 2013-09-24 | 2017-02-21 | Proteus Digital Health, Inc. | Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance |
US10084880B2 (en) | 2013-11-04 | 2018-09-25 | Proteus Digital Health, Inc. | Social media networking based on physiologic information |
US11950615B2 (en) | 2014-01-21 | 2024-04-09 | Otsuka Pharmaceutical Co., Ltd. | Masticable ingestible product and communication system therefor |
US10398161B2 (en) | 2014-01-21 | 2019-09-03 | Proteus Digital Heal Th, Inc. | Masticable ingestible product and communication system therefor |
JP2017537704A (en) * | 2014-12-05 | 2017-12-21 | エヌエムアール テクノロジー アーエス | Electrochemical device that emits ions |
US11433152B2 (en) | 2014-12-05 | 2022-09-06 | NMR Technology AS | Electrochemical device for releasing ions |
CN107404997A (en) * | 2014-12-05 | 2017-11-28 | Nmr技术股份有限公司 | For discharging the electrochemical appliance of ion |
US11051543B2 (en) | 2015-07-21 | 2021-07-06 | Otsuka Pharmaceutical Co. Ltd. | Alginate on adhesive bilayer laminate film |
US10797758B2 (en) | 2016-07-22 | 2020-10-06 | Proteus Digital Health, Inc. | Electromagnetic sensing and detection of ingestible event markers |
US10187121B2 (en) | 2016-07-22 | 2019-01-22 | Proteus Digital Health, Inc. | Electromagnetic sensing and detection of ingestible event markers |
US11529071B2 (en) | 2016-10-26 | 2022-12-20 | Otsuka Pharmaceutical Co., Ltd. | Methods for manufacturing capsules with ingestible event markers |
US11793419B2 (en) | 2016-10-26 | 2023-10-24 | Otsuka Pharmaceutical Co., Ltd. | Methods for manufacturing capsules with ingestible event markers |
CN107307853A (en) * | 2017-06-02 | 2017-11-03 | 唐山金万众科技有限公司 | A kind of capsule monitoring device |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002282219A (en) | Intracorporeal capsule | |
US8942818B2 (en) | Communication with an implantable medical device during implantation | |
EP2589333A1 (en) | Apparatus and system for long-term cutaneous cardiac monitoring | |
US10424975B2 (en) | Sensor module and kit for determining an analyte concentration | |
US8214156B2 (en) | System and method for improving data management between implantable medical devices and external devices | |
JP2002502641A (en) | Implantable device with digital waveform telemetry | |
WO2007065044A2 (en) | Communication system for medical devices | |
JPH09122083A (en) | Patient monitoring apparatus mountable regularly | |
JP2017504392A (en) | Built-in power supply type analyte sensor and device using the same | |
KR20140060164A (en) | Wireless chargable shoes which enables to transmit bio-information, method for managing health in wireless communication system, and wireless communication system used therein | |
EP3943150B1 (en) | System and method for managing bluetooth low energy advertising | |
US11284816B2 (en) | Multi-analyte continuous glucose monitoring | |
Lee | Miniaturized human insertable cardiac monitoring system with wireless power transmission technique | |
CN105615897B (en) | A kind of blood sugar monitor and its monitoring method | |
US20190274570A1 (en) | Electroencephalogram detection device and equipment | |
KR20120085065A (en) | Wearable body condition diagnosys apparatus and body condition diagnosys system including the same | |
US11278715B2 (en) | Lead assembly for networked implants | |
RU163942U1 (en) | MEDICAL TRANSMITTER | |
CN216907958U (en) | Heart rate detection device | |
CN211719008U (en) | BCG signal monitoring early warning device based on Bluetooth technology | |
CN216907959U (en) | Multifunctional heart rate detection device | |
JP6646177B2 (en) | Wearable device | |
KR20030041387A (en) | Biopotential Recording System using Mobile Phone | |
Loeffler et al. | Embedded medical devices: Pressure volume loops in rodents | |
CN212118154U (en) | BCG signal monitoring early warning device based on wifi technology |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070904 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100611 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100623 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20101019 |